Literature DB >> 33479464

Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study.

Tae Jun Kim1, Young-Ho Kim2, Chan Mi Heo3, Eun Ran Kim3, Sung Noh Hong3, Dong Kyung Chang3, Mi Yang4, Seonwoo Kim4.   

Abstract

Routine prophylaxis for venous thromboembolism (VTE) in Asian IBD patients has been controversial. We aimed to estimate the risk of VTE of Asian patients at different phases of IBD by incorporating patient-specific risk factors. In this cohort study, we analyzed the National Health Insurance claims data between 2012 and 2016 for the entire Korean population. We calculated incidence rates and hazard ratios for VTE. The overall VTE risk was higher in patients with IBD [adjusted hazard ratio (aHR), 2.06; 95% confidence interval (CI), 1.66-2.55], than in controls. When we compare the risk of VTE by different disease phases, the risk of VTE was the highest during post-operation period after IBD-related bowel surgery (aHR, 39.7; 95% CI 9.87-159.3), followed by during hospitalized periods with flare (aHR, 27.2; 95% CI 14.9-49.65) and during hospitalized periods with non-flare (aHR, 16.23; 95% CI 10.71-24.58). The incidence rate (per 1000 person-years) was 15.26 during hospitalized periods with a flare and 9.83 during hospitalized periods with non-flare. According to age groups, the incidence rate (per 1000 person-years) during hospitalized periods with flare was 14.53 in young patients (20-39 years) and 34.58 in older patients (60-80 years). During hospitalized periods with non-flare, the incidence rate was 3.55 in young patients and 23.61 in older patients. The prophylaxis of VTE for Asian patients with IBD should be recommended in older patients admitted to hospital and be considered in young patients who are hospitalized with a flare.

Entities:  

Year:  2021        PMID: 33479464     DOI: 10.1038/s41598-021-81657-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  21 in total

1.  The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.

Authors:  Marcus Harbord; Vito Annese; Stephan R Vavricka; Matthieu Allez; Manuel Barreiro-de Acosta; Kirsten Muri Boberg; Johan Burisch; Martine De Vos; Anne-Marie De Vries; Andrew D Dick; Pascal Juillerat; Tom H Karlsen; Ioannis Koutroubakis; Peter L Lakatos; Tim Orchard; Pavol Papay; Tim Raine; Max Reinshagen; Diamant Thaci; Herbert Tilg; Franck Carbonnel
Journal:  J Crohns Colitis       Date:  2015-11-27       Impact factor: 9.071

2.  Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study.

Authors:  Hyun Jung Kim; Hoo Jae Hann; Sung No Hong; Kyoung Hoon Kim; Il Min Ahn; Ji Yang Song; Sang Hyuk Lee; Hyeong Sik Ahn
Journal:  Inflamm Bowel Dis       Date:  2015-03       Impact factor: 5.325

3.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.

Authors:  Matthew J Grainge; Joe West; Timothy R Card
Journal:  Lancet       Date:  2010-02-08       Impact factor: 79.321

4.  Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991.

Authors:  N Morita; S Toki; T Hirohashi; T Minoda; K Ogawa; S Kono; A Tamakoshi; Y Ohno; T Sawada; T Muto
Journal:  J Gastroenterol       Date:  1995-11       Impact factor: 7.527

Review 5.  Venous thromboembolism in inflammatory bowel disease: an epidemiological review.

Authors:  Sanjay K Murthy; Geoffrey C Nguyen
Journal:  Am J Gastroenterol       Date:  2011-03-15       Impact factor: 10.864

Review 6.  Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.

Authors:  Geoffrey C Nguyen; Charles N Bernstein; Alain Bitton; Anthony K Chan; Anne M Griffiths; Grigorios I Leontiadis; William Geerts; Brian Bressler; J Decker Butzner; Marc Carrier; Nilesh Chande; John K Marshall; Chadwick Williams; Clive Kearon
Journal:  Gastroenterology       Date:  2014-01-22       Impact factor: 22.682

7.  Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.

Authors:  Geoffrey C Nguyen; Justina Sam
Journal:  Am J Gastroenterol       Date:  2008-08-05       Impact factor: 10.864

8.  Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease.

Authors:  H Yuhara; C Steinmaus; D Corley; J Koike; M Igarashi; T Suzuki; T Mine
Journal:  Aliment Pharmacol Ther       Date:  2013-04-02       Impact factor: 8.171

9.  Increasing incidence and lifetime risk of inflammatory bowel disease in Taiwan: a nationwide study in a low-endemic area 1998-2010.

Authors:  Chiao-Hsiung Chuang; Sheng-Hsiang Lin; Chiung-Yu Chen; Bor-Shyang Sheu; Ai-Wen Kao; Jung-Der Wang
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

10.  Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom.

Authors:  Consuelo Huerta; Saga Johansson; Mari-Ann Wallander; Luis A García Rodríguez
Journal:  Arch Intern Med       Date:  2007-05-14
View more
  1 in total

1.  Is the Risk for Venous Thromboembolism in East Asian Patients with Inflammatory Bowel Disease Comparable to That in Western Patients?

Authors:  Sung Wook Hwang
Journal:  Gut Liver       Date:  2022-07-15       Impact factor: 4.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.